noom med glp 1 Interesting claim by Noom Med…

Emerging evidence suggests these agents also exert direct dermatologic effects

You will then receive a personalized dosing protocol that starts at the standard initiation dose of 0.25 mg weekly and titrates gradually upward over approximately 16 to 20 weeks toward the therapeutic target dose of 2.4 mg weekly allowing your body time to adjust and minimizing the nausea and gastrointestinal side effects that occur when the dose is escalated too quickly

While Zepbound is not directly known to cause NAION, its effects on blood sugar and potential impacts on vascular health in diabetic patients could theoretically contribute to an increased risk

Theres going to be more and more of this usage in the United States, and if we want to participate, Zammer concluded, this is our time to do it.